(Q44499095)

3 December 2017

title

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up (English)

1 reference

3 December 2017

1

1 reference

3 December 2017

8

1 reference

3 December 2017

2

Judith Manola

1 reference

3 December 2017

Laurie Bittmann

3

1 reference

3 December 2017

Adam Brufsky

4

1 reference

3 December 2017

Irving D Kaplan

5

1 reference

3 December 2017

Matthew R Smith

6

1 reference

3 December 2017

Donald S Kaufman

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

62

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

99-104

1 reference

Long-term effects of androgen deprivation therapy in prostate cancer patients

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Anti-androgenic effects of combination finasteride plus flutamide in patients with prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Combined finasteride and flutamide therapy in men with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Survival of patients who had salvage castration after failure on bicalutamide monotherapy for stage (D2) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Orchidectomy following failure of antiandrogen monotherapy in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900145-6

7 January 2021

10.1016/S0090-4295(03)00145-6

Identifiers

DOI

1 reference

3 December 2017

1 reference